Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of the Addition of Letrozole in in Vitro Fertilization (IVF) Following a Prior Failed IVF Cycle With an Antagonist or Short Protocol Without Letrozole

NCT05677828 is registered in ClinicalTrials.gov with Clinique Ovo as lead sponsor.

NCT NCT05677828
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05677828 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of the Addition of Letrozole in in Vitro Fertilization (IVF) Following a Prior Failed IVF Cycle With an Antagonist or Short Protocol Without Letrozole
Lead sponsor
Clinique Ovo
Phase
Observational
Overall status
Completed
Start date
February 15, 2022
Completion date
January 31, 2023
Enrollment
426 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diminished ovarian reserve